Krueger Cornelia, Thommes Markus, Kleinebudde Peter
Heinrich-Heine-University, Duesseldorf, Germany.
Eur J Pharm Biopharm. 2014 Oct;88(2):483-91. doi: 10.1016/j.ejpb.2014.06.006. Epub 2014 Jun 17.
Microcrystalline cellulose II (MCC II(1)) is a polymorph of commonly used MCC I; in 2010 it was introduced as new pelletization aid in wet-extrusion/spheronization leading to fast disintegrating pellets. Previous investigations suggested that the storage of the resulting pellets affect the disintegration behavior, the non-hygroscopic substance chloramphenicol that showed no polymorphism or hydrate formation due to relative humidity was used for the investigations. Therefore, theophylline-monohydrate that can dehydrate during storage, but also during manufacturing and drying was used for this study to confirm the results of the previous study and give a more detailed overview of the influence of recrystallization of theophylline monohydrate on disintegration. Storage recommendations should be derived. MCC II-based pellets were prepared of binary mixtures containing 10%, 20% or 50% MCCII as pelletization aid and theophylline-monohydrate as API. These pellets were stored at different relative humidity (0-97%rH; 20°C); the influence on their disintegration and drug release was investigated. The storage conditions had an impact on pellet disintegration. Low relative humidities (⩽ 40%rH) led to a conversion of the monohydrate to the anhydrous form. Newly grown crystals formed a kind of network around the pellet and inhibited the disintegration. High relative humidity (>80%rh) affected the disintegration caused by changes in the MCCII as already seen in the previous study. Due to the changed disintegration behavior also the drug release and release kinetic changed. Therefore, for theophylline containing pellets a storage humidity of 55%rH to 80%rH (20°C) is recommended. All in all, these investigations substantiate the knowledge of MCCII-based pellets providing a better basis for adequate storage conditions of MCCII based pellets.
微晶纤维素II(MCC II(1))是常用微晶纤维素I的一种多晶型物;2010年,它作为一种新型制粒助剂被引入湿法制粒/滚圆法中,可制得快速崩解的颗粒。先前的研究表明,所得颗粒的储存会影响其崩解行为,由于相对湿度,无吸湿性物质氯霉素未表现出多晶型或水合物形成,因此该物质被用于相关研究。因此,本研究使用了在储存过程中以及制造和干燥过程中都会脱水的一水合氨茶碱,以证实先前研究的结果,并更详细地概述一水合氨茶碱重结晶对崩解的影响。应得出储存建议。以含10%、20%或50% MCCII作为制粒助剂和一水合氨茶碱作为活性药物成分的二元混合物制备了基于MCC II的颗粒。这些颗粒在不同相对湿度(0 - 97%rH;20°C)下储存;研究了其对崩解和药物释放的影响。储存条件对颗粒崩解有影响。低相对湿度(⩽ 40%rH)会导致一水合物转化为无水形式。新生长的晶体在颗粒周围形成一种网络,抑制了崩解。高相对湿度(>80%rh)影响崩解,这与先前研究中观察到的MCCII变化有关。由于崩解行为的改变,药物释放和释放动力学也发生了变化。因此,对于含氨茶碱的颗粒,建议储存湿度为55%rH至80%rH(20°C)。总而言之,这些研究证实了基于MCCII的颗粒的相关知识,为基于MCCII的颗粒的适当储存条件提供了更好的基础。